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Aim: Pain represents the most frequent cause for patient admission to emergency departments 
(EDs). Oligoanalgesia is a common problem in this field. The aims of this study were to assess 
prevalence and intensity of pain in patients who visited a second-level urban ED and to evaluate 
the efficacy of pharmacological treatment administered subsequent to variations in pain intensity.
Methods: A 4-week prospective observational study was carried out on 2,838 patients who 
visited a second-level urban ED. Pain intensity was evaluated using the Numeric Rating Scale 
at the moment of triage. The efficacy of prescribed analgesic therapy was evaluated at 30 and 
60 minutes, and at discharge. Data concerning pain intensity were classified as absent, slight, 
mild, or severe. Pain was evaluated in relation to the prescribed therapy.
Results: Pain prevalence was 70.7%. Traumatic events were the primary cause in most cases 
(40.44%), followed by pain linked to urologic problems (13.52%), abdominal pain (13.39%), and 
nontraumatic musculoskeletal pain (7.10%). Only 32.46% of patients were given pharmacological 
therapy. Of these, 76% reported severe pain, 19% moderate, and 5% slight, and 66% received 
nonsteroidal anti-inflammatory drugs or paracetamol, 4% opioids, and 30% other therapies. A 
difference of at least 2 points on the Numerical Rating Scale was observed in 84% of patients 
on reevaluation following initial analgesic therapy.
Conclusion: Pain represents one of the primary reasons for visits to EDs. Although a notable 
reduction in pain intensity has been highlighted in patients who received painkillers, results 
show that inadequate treatment of pain in ED continues to be a problem.
Keywords: pain, emergency department, oligoanalgesia, pain treatment, pain assessment, 
NSAIDs, opioids, methoxyflurane, traumatic pain, abdominal pain
Introduction
Pain is one of the most common symptoms mentioned by patients at emergency 
departments (EDs).1,2 Painful conditions cause over 70% of all ED visits in the US and 
Canada.3 Chang et al4 reported that from 2000 to 2010 in the United States, ~45.4% 
of ED visits were associated with a primary symptom or diagnosis of pain.
Previous studies reported that many patients suffering from acute pain receive 
inadequate or no treatment at ED.5,6 Despite this, studies on the prevalence of pain 
in EDs are still scarce.1,2,7 In addition, pain often represents an underestimated and 
undertreated problem in Italy.8
In 1989, Wilson and Pendleton coined the term “oligoanalgesia” to describe the 
lack of adequate treatment of pain in terms of dosages and rapidity of administra-
tion of analgesics for ED patients.9 To date, no recognized universal instruments are 
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available to define expectations and outline objectives of 
pain relief. Available instruments and pain evaluation tables 
all beg the question “What does a score of x on the scale of 
pain mean exactly?”
Results obtained by Farrar10 in his study to determine 
the limits to evaluate important variations in pain show that 
a 2-point difference on the Numerical Rating Scale (NRS) 
scale is significant.
Pain therapy should be parallel to reaching diagnosis. 
Pain is considered the fifth vital sign, and thus, it should be 
evaluated at a patient’s visit to the ED11 and reevaluated once 
therapy has been administered. Most used drugs in everyday 
ED clinical practice are nonsteroidal anti-inflammatory drugs 
(NSAIDs) – especially ibuprofen, ketoprofen, and ketorolac – 
and paracetamol. They can be administered either enterally 
or parenterally. Tramadol or opioids such as morphine, 
hydromorphone, or fentanyl can also be used. Association 
of analgesics with adjuvant nonanalgesic drugs can improve 
their effects or mitigate adverse side effects. 
Pain evaluation is important, and it is used as a quality 
indicator.12,13
Literature emphasizes the need to shift research attention 
from the prompt diagnosis of the underlying condition of pain 
toward that of immediate pain relief, attempting to identify 
therapies that lead to a ready and efficient analgesic which 
is as side effect-free as possible.5,14
It is critical to treat acute pain not only to decrease suffer-
ing but also to maximize healing and minimize the chances 
of progression to a chronic pain condition.5
Methods
This prospective observational study was performed in 
accordance with the Good Clinical Practice (GPC) Guide-
lines, the EU CT Directive 2001/20.EC, GCP Commission 
Directive 2005/28/EC, and the Declaration of Helsinki 
(2008). The study was referred to the Cagliari Teaching 
Hospital  Independent Ethical Committee that approved it as 
a low-intervention observational study. The Ethical Commit-
tee reviewed the study and established the exemption from 
inclusion in the National Observational Study Register. This 
study was performed in a second-level ED in Cagliari (Italy) 
to which about 35,000 patients are referred annually. Data on 
patients who accessed the ED were collected over a 4-week 
period. The primary study aim was to observe and describe 
the access of patients who complained of pain at the moment 
of triage, comparing the data obtained with those available in 
literature. The secondary aim was to evaluate the pharmaco-
logical therapies through the variations of pain from admission 
to the ED to discharge, during hospitalization, or at home.
The study enrolled consecutively patients aged 18, reg-
istered at the triage of the ED during the study period. A 
written informed consent was obtained from all participants. 
Exclusion criteria were all conditions that rendered data 
collection impossible or only partially possible: nonconsent 
by the patient, alterations in states of consciousness (coma, 
drunkenness, psychomotor agitation, intoxication), cases of 
sexual abuse or domestic violence, prisoners, or conditions 
that led to the patient being referred directly for medical 
observation. The study collected demographic data (age 
and gender), the main reason for ED access, and element to 
assess patient pain by using the 11-point evaluation scale or 
NRS (Figure 1).
Each patient was asked if he or she could evaluate his or 
her level of pain on a scale from 0 to 10, where 0 equaled an 
absence of pain and 10 the maximum level. Pain intensity 
evaluated at the moment of triage was indicated as “t
0
”. All 
analgesic therapies administered to patients and their clinical 
efficacy were evaluated by ED personnel. Pain levels were 
reevaluated 30 minutes after administration of therapy (t
1
) 
at 60 minutes, if a second dose was required (t
2
), and in all 
patients treated at discharge (t
3
). Any side effects correlated 
to the analgesic drugs delivered were recorded.
Collected data were then stored in an Access database 
with security code protection.
Although translating continuous measures such as NRS 
into discrete categories is not straightforward,18 for the benefit 
of the analysis, data on pain intensity reported by patients at 
triage (t
0
) with the 11-point NRS were classified into four cat-
egories: no pain (score =0), slight pain (score 1–3), moderate 
pain (score 4–6), and severe pain (7–10),8 as shown in Table 1.
Figure 1 The Numerical Rating Scale (NRS).
Pain score 0–10 NRS
0–10 NRS
0 1
No pain Worst pain ever
2 3 4 5 6 7 8 9 10
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Results
During the study period, a total of 2,838 patients accessed the 
ED. At triage, 1,035 patients were enrolled. The other 1,803 
were excluded because they did not satisfy protocol criteria.
Of the 1,035 enrolled subjects, 732 (70.7%) reported a 
painful symptomatology, while the remaining 303 (29.3%) 
reported no pain.
Of the 732 patients who reported pain, 48 (6.56%) 
declined medical examination; the other 684 (93.44%) 
accessed the medical center and 222 (32.46%) were treated 
(Figure 2).
Analysis of the data on the 732 patients who reported 
pain at the moment of triage (t
0
) revealed the presence of 
slight pain in 60 (8.20%), moderate pain in 223 (30.46%), 
and severe pain in 449 (61.34%) patients (Table 1).
From the analysis of pain prevalence at t
0
 (n=732), the 
highest number of accesses was due to traumatic events 
(n=296; 40.44%), urological pathologies (n=99; 13.52%), 
abdominal pain (n=98; 13.39%), and nontraumatic muscu-
loskeletal pain (n=52; 7.10%) (Table 2).
Of the patients who were prescribed analgesic therapy, 6 
(2.70%) left before conclusion of the diagnostic therapeutic 
Table 1 NRS score at triage in all interviewed patients (N=1,035)
Category NRS 
score
Patients, n Patients in category, 
n (%)
No pain 0 303 303 (29.27%)
Slight pain 1 17 60 (5.8%)
2 15
3 28
Moderate pain 4 41 223 (21.55%)
5 62
6 120
Severe pain 7 173 449 (43.38%)
8 141
9 78
10 57
Abbreviation: NRS, Numerical Rating Scale.
Figure 2 Number of patients enrolled in the study.
Total number of patients
(n=2,838)
Pain (n=732) No pain (n=303)
Interviewed
(n=1,035)
Declined
examination
(n=48)
Examined
patients
(n=684)
Treated patients
(n=222) Untreated patients(n=462)
Excluded
(n=1,803)
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evaluation, and so it was not possible to assess outcome on 
discharge.
The average age of treated patients was 45.69±18.35 
years (range 18–88 years); 52% (n=115) were male and the 
remaining 48% (n=107) female; no significant difference in 
average NRS scores between males (mean NRS 7.30) and 
females (mean NRS 7.55) was observed.
Trauma victims and patients with urological (eg, renal 
colic, bladder infections, etc), abdominal (eg, appendicitis, 
cholecystitis, etc), and nontraumatic musculoskeletal pain 
(neck pain, low back pain, etc) reported higher scores on 
the NRS, with a mean of 6.08 (median =6), 7.24 (median 
=7), 7.44 (median =8), and 7.56 (median =8), respectively.
Two hundred and twenty-two (32.46%) of the 684 
examined patients received analgesics (Table 3). The initial 
pharmacological treatment of painful symptomatologies 
was nonopioid analgesics (NSAIDS or paracetamol) in 146 
cases (66%), weak opioids (tramadol), and strong opioids 
(morphine) in 8 (4%) cases.
Of the 222 patients who were prescribed analgesics in the 
moderate pain group (n=43; 19.37%) 19 received NSAIDs, 
5 received NSAIDs plus adjuvants, and 19 were treated with 
other drugs. Of the patients reporting severe pain (n=168; 
75.68%), 115 were treated with nonopioid analgesics (in 34 
cases, nonopioid drugs plus adjuvants), 8 with opioids, and 
45 with other drugs. No substantial differences in response to 
pharmacological therapy, evaluated as a reduction of NRS pain 
score, were revealed between males and females, although the 
highest average reduction was seen in females (=4.39 points) 
compared to males (=3.97 points). A reduction in NRS score 
was observed in 156 patients (70.27%) on reevaluation of 
pain following initial treatment; this reduction was of at least 
Table 2 Pain intensity at t0 for the four main causes of ED admission
Category NRS t0 Patients complaining of pain at admission (n=732; 70.7%)
Traumatic
(n=296; 40.44%)
Urological 
(n=99; 13.52%)
Abdominal  
(n=98; 13.39%)
Nontraumatic muscoloskeletal  
(n=52; 7.10%)
Slight pain 1 11 1 1 0
2 9 3 0 1
3 17 3 0 0
Moderate pain 4 22 3 7 2
5 34 7 5 3
6 67 11 8 6
Severe pain 7 69 22 21 11
8 38 22 32 14
9 16 12 16 7
10 13 15 8 8
NRS mean 6.08 7.24 7.44 7.56
NRS median 6 7 8 8
Abbreviations: ED, emergency department; NRS, Numerical Rating Scale; t0; the first admission at triage.
Table 3 Overview of drugs employed: dose and route and frequency of administration
Drug type Drug used Dose Route of administration Frequency of administration
Analgesics Paracetamol 1 g Intravenous 31
Diclofenac 75 mg Intramuscular 8
Ketoprofene 100 mg Intravenous 75
Ketorolac 30 mg Intravenous 38
Tramadol 100 mg Intravenous 7
Morphine 10 mg Intramuscular 1
Adjuvants Hydrocortisone 100 mg Intravenous 31
Betametasone 4 mg Intravenous 17
Diazepam 2–4 mg Oral 2
Clorphenamine 10 mg Intramuscular 6
Floroglucinol 40 mg Intravenous 28
Levosulpiride 25 mg Intravenous 16
Metoclopramide 10 mg Intravenous 2
Omeprazole 40 mg Intravenous 34
Ranitidine 50 mg Intravenous 74
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2 points in 84% of patients. Forty-nine individuals (22.07%) 
were given second doses of analgesics. No side effects to the 
prescribed drugs were observed during the study in any patient.
The evaluation NRS at t
0
 and at discharge in the four main 
causes of pain is shown in Table 4.
Discussion
A prevalence of pain of 70.7% in the ED is revealed from our 
study, which is similar to that reported in literature,3,4 although 
several studies were performed over a subtype of patient and 
pain (eg, posttraumatic pain). The 7-day prospective study by 
Johnston et al1 evaluated pain prevalence and intensity in two 
EDs and reported a prevalence among adults equal to 71%. 
A study by Tanabe and Buschmann2 on 203 patients aged 
≥18 years obtained a prevalence of 78%. In another study 
on 726 subjects, 78% complained of pain on admission.7 
These were prospective studies that not only evaluated pain 
prevalence but also severity and efficacy of therapy in differ-
ent groups of patient complaining pain from different causes.
The importance of prospective studies derives from the 
inability of retrospective studies to assess pain severity, 
therapy response,2 or whether the pain was clinically impor-
tant at the time as the opportunity to interact with the patient, 
the only person who can give a valid indication of his pain, 
no longer exists at the moment of data collection.
In an emergency setting, one-dimensional pain intensity 
evaluation scales are employed for their simplicity of appli-
cation as they are extremely user-friendly for the majority 
of patients.15 The Visual Analogical Scale and the NRS of 
acute pain are the most widely used and validated in emer-
gency situations and have proven to be more reliable than 
the Visual Rating Scale.16 The use of evaluation scales on 
admission to an ED and during the course of therapy appears 
to allow doctors to monitor the situation better and modulate 
analgesia, offering notable improvement in pain management 
in emergencies.17 Although trying to translate a number into 
a category like slight, moderate, or severe is probably not 
straightforward, this seems to be necessary in order to draft 
useful pain protocols.8–18
Of the 684 patients who visited the ED effectively suf-
fering from pain, only 222 (32.46%) were given pharma-
cological therapy. This mirrors data that has been reported 
in literature, or rather, that 40%–70% of users who access 
the ED due to pain do not receive analgesia or are offered 
inadequate treatment.5,19,20
In our study, 11.48% of patients complaining of pain left 
the ED before seeing a clinician or before discharge; this 
result is higher than the 6%–9% reported in literature.21 One T
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of the causes of this can be found in the frequent overcrowd-
ing of the ED, which often means a failure in the service 
offered because of the long waiting times and reduces drasti-
cally patient satisfaction levels.13,22,23,24
The reasons for undertreatment and inadequate manage-
ment of pain therapy in ED include underevaluation and 
scarce accuracy during assessment; in fact, the intensity 
of the reported pain is often considered exaggerated by the 
nurses at triage.25,26
These situations could be improved with the routine 
registration of pain intensity by using Visual Analog Scale/
NRS at the moment of triage and with precocious analgesia 
protocols.8,19,20 Another cause of oligoanalgesia is the absence 
of specific pain management courses;26 specific training is 
necessary to improve the knowledge and the attitudes of 
health professionals toward the management and treatment 
of patients’ pain.27 The untreated pain still remains an unmet 
need in ED. All analgesic drugs currently used in ED show 
some weak points (oral formulation with slow onset of action, 
need of monitoring patients receiving opioids) and also have 
side effects or contraindications (eg, NSAIDs in patients with 
cardiovascular risk).
Inhaled analgesics are not commonly used in Italy. In spite 
of clinical benefits, nitric oxide (N
2
O) use is limited by its 
poor practicality (considerable weight and size of the tank), 
risk of cross-contamination, and occupational exposure.
Methoxyflurane is an inhaled analgesic supported by 
recent clinical data confirming its efficacy and tolerability;28,29 
it has been extensively used since the 1970s in Australia and 
is currently available in some European countries (UK and 
Ireland). Since it shows a fast onset and offset of action and 
is self-administered through a portable, lightweight, and 
easy-to-use device, it could be an advantageous option in 
emergency setting.
The conviction that the treatment of pain can interfere 
with diagnostic tests still persists today,30 or that the prescrip-
tion of opioids can favor addiction.26
This was underlined by Marinangeli et al,31 in 2009, in a 
study on the use of analgesics in prehospital emergency situa-
tions in which they concluded that all emergency ambulances 
should be equipped with opioids and other analgesics for the 
treatment of pain. There are no “best opioids” in acute pain 
treatment, but some opioids are better than others in some 
patients. The opioids present different pharmacokinetic and 
pharmacodynamic properties; thus, opioid choice must be 
tailored for each patient.
A reduction in pain intensity of at least 2 points on the 
NRS scale, the value that corresponds to the cutoff score 
for pain necessary for an important result from a clinical 
viewpoint, was reported by 84% of the treated patients.10,16 
Of the 296 patients who complained of pain following trau-
matic events, only 32 (10.81%) were given analgesics and no 
opioids, even though 15 reported severe pain. This contrasts 
with data reported in other studies.17 This study shows that 
98 patients complained of abdominal pain, and of these, only 
42 were given analgesics, reporting a significant average 
reduction of 4.3 points in pain score, which is in accordance 
with the results of Farrar et al.10
Our results show that pain relief can be achieved with no 
opioid drugs as well.
Although a number of emergency doctors maintain 
that the use of painkillers does not compromise medical 
examination, most procrastinate analgesia until the patient’s 
diagnostic evaluation is completed.32,33
Diagnosis and treatment of pain should be performed 
as speedily as possible and begin, where possible and safe, 
before arrival in hospital.31 Analgesia in the ED is still largely 
inadequate today;7,11,34 in order to obviate this, we believe it 
is fundamental that emergency doctors fully understand the 
pathophysiological implications of acute pain, which not 
only signifies sufferance for the patient but is also the cause 
of functional alteration of numerous apparatus including the 
cardiovascular and endocrinal systems. Inadequate treatment 
of acute pain can aggravate the clinical pictures of the more 
critical patients and those less able to adapt to a worsening 
of their illness (the elderly, cardiopaths, cancer patients, 
diabetics, etc.). In consideration of this, it could be useful 
to intensify pain treatment training and to create flexible 
protocols for the treatment of acute pain in ED.
Correct pain management requires knowledge about 
pharmacological properties of opioids, in particular the 
assessment of risks related to opioid diversion, abuse, and 
misuse.35–36
In this setting, pain treatment protocols should be imple-
mented at the time of triage, immediately after patient’s 
admission in the ED. Patients should be frequently asked 
about their pain score through validated pain score scales, as 
we usually do with other vital signs, and the score should be 
registered step by step into the patient’s clinical record.5,12,20
Limitations
A number of factors limit our study. First of all, this is a 
single-center study, and a 4-week duration is a short time 
in order to obtain a global view about ED pain. Another 
limitation is the lack of data about a possible prehospital 
pain treatment.
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Unfortunately, nonpharmacological pain control meth-
ods, including psychosocial treatment, were not evaluated 
in this work.
Conclusion
This study confirms that pain, whatever its etiology, repre-
sents one of the principal reasons for visit to and treatment at 
an ED. Despite significant reduction in pain levels in recipi-
ents of analgesics, our study shows that undertreatment of 
pain in the ED is still a problem in need of solutions.
Disclosure
The authors report no conflicts of interest in this work.
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